Close Menu

NEW YORK (GenomeWeb) – Signature Science said yesterday that it has been awarded a contract from the US Centers for Disease Control and Prevention to evaluate and develop molecular tools to detect and follow the spread of specific bacteria and microbial communities in healthcare settings.

Brian Schimmoller, vice president at Austin, Texas-based Signature Science, noted in an email that the 12-month contract has a value of approximately $560,000.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The editorial board of the Pittsburgh Post-Gazette says other lawmakers should take Florida's approach and provide additional protections against genetic discrimination.

The Hill reports 17 states and the District of Columbia are suing over a new policy that would strip international students of their visas if they only attend classes online.

Centers for Disease Control and Prevention employees call on the agency to label racism a public health crisis and examine its own policies, NPR reports.

In PNAS this week: genetic evidence for Inca resettlement, analysis of spermatogonial stem cell transcriptomes, and more.